Relay Therapeutics, Inc. RLAY Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s total liabilities?
- Relay Therapeutics, Inc. (RLAY) reported total liabilities of $57.43M in Q1 2026.
- How has Relay Therapeutics, Inc.'s total liabilities changed year-over-year?
- Relay Therapeutics, Inc.'s total liabilities decreased by 26.6% year-over-year, from $78.28M to $57.43M.
- What is the long-term trend for Relay Therapeutics, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s total liabilities has grown at a 8.2% compound annual growth rate (CAGR), from $36.54M to $54.27M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.